Literature DB >> 16801405

Multiple cis-acting sequences mediate upregulation of the MDR1 efflux pump in a fluconazole-resistant clinical Candida albicans isolate.

Davina Hiller1, Stephanie Stahl, Joachim Morschhäuser.   

Abstract

Overexpression of the MDR1 gene, which encodes a multidrug efflux pump of the major facilitator superfamily, is a frequent cause of resistance to the antimycotic agent fluconazole and other metabolic inhibitors in clinical Candida albicans strains. Constitutive MDR1 overexpression in such strains is caused by mutations in as yet unknown trans-regulatory factors. In order to identify the cis-acting sequences in the MDR1 regulatory region that mediate constitutive MDR1 upregulation, we performed a promoter deletion analysis in the genetic background of an MDR1-overexpressing clinical C. albicans isolate. We found that several different regions in the MDR1 promoter can mediate MDR1 overexpression in this isolate. In contrast, deletion of one of these regions abolished benomyl-induced MDR1 expression in a C. albicans laboratory strain. These results suggest that multiple transcription factors control expression of the MDR1 efflux pump in C. albicans and that the mutation(s) that causes constitutive MDR1 overexpression and drug resistance in clinical C. albicans isolates affects the activities of several of these transcription factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16801405      PMCID: PMC1489804          DOI: 10.1128/AAC.00196-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

Review 1.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

2.  Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor.

Authors:  S Wirsching; S Michel; G Köhler; J Morschhäuser
Journal:  J Bacteriol       Date:  2000-01       Impact factor: 3.490

3.  Molecular aspects of fluconazole resistance development in Candida albicans.

Authors:  R Franz; M Ruhnke; J Morschhäuser
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

4.  Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.

Authors:  S Perea; J L López-Ribot; W R Kirkpatrick; R K McAtee; R A Santillán; M Martínez; D Calabrese; D Sanglard; T F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

5.  Analysis of phase-specific gene expression at the single-cell level in the white-opaque switching system of Candida albicans.

Authors:  A Strauss; S Michel; J Morschhäuser
Journal:  J Bacteriol       Date:  2001-06       Impact factor: 3.490

6.  Isogenic strain construction and gene targeting in Candida dubliniensis.

Authors:  P Staib; G P Moran; D J Sullivan; D C Coleman; J Morschhäuser
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

7.  Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates.

Authors:  S Wirsching; S Michel; J Morschhäuser
Journal:  Mol Microbiol       Date:  2000-05       Impact factor: 3.501

8.  Expression of a chromosomally integrated, single-copy GFP gene in Candida albicans, and its use as a reporter of gene regulation.

Authors:  J Morschhäuser; S Michel; J Hacker
Journal:  Mol Gen Genet       Date:  1998-02

9.  Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.

Authors:  J L Lopez-Ribot; R K McAtee; L N Lee; W R Kirkpatrick; T C White; D Sanglard; T F Patterson
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

10.  Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains.

Authors:  R Franz; S L Kelly; D C Lamb; D E Kelly; M Ruhnke; J Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

View more
  18 in total

Review 1.  Multidrug resistance in fungi.

Authors:  Kailash Gulshan; W Scott Moye-Rowley
Journal:  Eukaryot Cell       Date:  2007-09-14

Review 2.  Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.

Authors:  Leah E Cowen; William J Steinbach
Journal:  Eukaryot Cell       Date:  2008-03-28

3.  Functional analysis of cis- and trans-acting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system.

Authors:  Alix T Coste; Jérôme Crittin; Christopher Bauser; Bettina Rohde; Dominique Sanglard
Journal:  Eukaryot Cell       Date:  2009-06-26

4.  Transcriptional regulation of MDR1, encoding a drug efflux determinant, in fluconazole-resistant Candida albicans strains through an Mcm1p binding site.

Authors:  Perry J Riggle; Carol A Kumamoto
Journal:  Eukaryot Cell       Date:  2006-10-13

5.  Differential requirement of the transcription factor Mcm1 for activation of the Candida albicans multidrug efflux pump MDR1 by its regulators Mrr1 and Cap1.

Authors:  Selene Mogavero; Arianna Tavanti; Sonia Senesi; P David Rogers; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

6.  Inducible and constitutive activation of two polymorphic promoter alleles of the Candida albicans multidrug efflux pump MDR1.

Authors:  Christoph Sasse; Rebecca Schillig; Alexandra Reimund; Julia Merk; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

7.  The zinc cluster transcription factor Ahr1p directs Mcm1p regulation of Candida albicans adhesion.

Authors:  Christopher Askew; Adnane Sellam; Elias Epp; Jaideep Mallick; Hervé Hogues; Alaka Mullick; André Nantel; Malcolm Whiteway
Journal:  Mol Microbiol       Date:  2010-12-30       Impact factor: 3.501

8.  An MDR1 promoter allele with higher promoter activity is common in clinically isolated strains of Candida albicans.

Authors:  Igor Bruzual; Carol A Kumamoto
Journal:  Mol Genet Genomics       Date:  2011-10-05       Impact factor: 3.291

9.  Multidrug-resistant transporter mdr1p-mediated uptake of a novel antifungal compound.

Authors:  Nuo Sun; Dongmei Li; William Fonzi; Xin Li; Lixin Zhang; Richard Calderone
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

10.  Identification of the Candida albicans Cap1p regulon.

Authors:  Sadri Znaidi; Katherine S Barker; Sandra Weber; Anne-Marie Alarco; Teresa T Liu; Geneviève Boucher; P David Rogers; Martine Raymond
Journal:  Eukaryot Cell       Date:  2009-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.